Skip to content

Blog

Grants

NIH/NIDDK Phase I SBIR Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing. NIH/NIDDK Phase II SBIR Follow-on proposal to our awarded NIH-SBIR… Read More »Grants